Watkins Tim

Watkins Tim is listed in filings as CMO & Head of Development at Contineum Therapeutics, Inc. Class A Common Stock. This profile follows SEC Form 4 activity through Mar 2, 2026, including sale activity. Recent filings connect the profile to Contineum Therapeutics, Inc. Class A Common Stock (CTNM). The current snapshot covers public activity from Apr 28, 2025 to Mar 2, 2026. Reported amounts are shown as $54.2K to $2.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.